EFFECT OF EZH2 GENE EDITING WITH CRISPR/CAS9 IN LUNG CANCER CELLS

Vol 1, 2023 - 169079
Trabalho
Favoritar este trabalho
Como citar esse trabalho?
Resumo

Lung cancer is the leading cause of cancer death, annually resulting in more than one million deaths worldwide. Lung adenocarcinoma is the most common form of lung cancer and has an average 5-yr survival rate of 15%, mainly because of late-stage detection and a paucity of late-stage treatments. The main oncogenic pathway is MAPK with mutations in KRAS and EGFR, and high prevalence of inactivating mutations in TP53. In this context, the investigation of new molecular alterations could contribute to the understanding of the biology of this aggressive cancer. In that sense, the increase in PRC2/EZH2 complex activity has been reported in different types of cancer, especially in aggressive histotypes. EZH2/PRC2 is highly expressed during development, acting in the chromatin silencing through the trimethylation of histone H3K27. Thus, developing strategies to inhibit PRC2/EZH2 function by blocking EZH2 methyltransferase activity using CRISPR/Cas9-mediated gene editing may contribute to the understanding of lung cancer biology.

Compartilhe suas ideias ou dúvidas com os autores!

Sabia que o maior estímulo no desenvolvimento científico e cultural é a curiosidade? Deixe seus questionamentos ou sugestões para o autor!

Faça login para interagir

Tem uma dúvida ou sugestão? Compartilhe seu feedback com os autores!

Eixo Temático
  • 16 - Terapia Gênica e Celular, Biologia Omics